High affinity anti-CD3 antibodies, and methods for their generation and use
US-12552863-B2 · Feb 17, 2026 · US
Adimab Llc holds 124 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 124 |
| Recent patents | 30 |
| First publication | Dec 24, 2015 |
| Latest publication | Feb 17, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12552863-B2 · Feb 17, 2026 · US
US-12529164-B2 · Jan 20, 2026 · US
US-2025388653-A1 · Dec 25, 2025 · US
US-2025382359-A1 · Dec 18, 2025 · US
US-2025313612-A1 · Oct 9, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12552863-B2 · Feb 17, 2026 · US
US-12529164-B2 · Jan 20, 2026 · US
US-2025388653-A1 · Dec 25, 2025 · US
US-2025382359-A1 · Dec 18, 2025 · US
US-2025313612-A1 · Oct 9, 2025 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| C07K2317/92 | 86 |
| C07K2317/565 | 72 |
| A61K2039/505 | 72 |
| C07K2317/21 | 68 |
| C07K2317/76 | 67 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 124 |
| Human Necessities | 79 |
| Physics | 39 |
| Operations & Transport | 3 |
| Electricity | 1 |
| Cross-Sectional Technologies | 1 |
Answers are generated from the same data shown on this page.